Jonathan Jay Mazelsky, President and CEO at IDEXX LABORATORIES INC /DE (IDXX), sold 46,652 shares at $650.67 ($30.7M) on 2026-02-26, disclosed to the SEC on 2026-03-02.
Open-market sale of $30.7M IDXX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $650.67 | 1,281 | $834K | 2.7% |
| 2 | $650.67 | 1,281 | $834K | 2.7% |
| 3 | $651.49 | 1,095 | $713K | 2.3% |
| 4 | $651.49 | 1,095 | $713K | 2.3% |
| 5 | $652.49 | 1,669 | $1.1M | 3.6% |
| 6 | $652.49 | 1,669 |
| $1.1M |
| 3.6% |
| 7 | $653.68 | 1,171 | $765K | 2.5% |
| 8 | $653.68 | 1,171 | $765K | 2.5% |
| 9 | $654.63 | 1,111 | $727K | 2.4% |
| 10 | $654.63 | 1,111 | $727K | 2.4% |
| 11 | $655.85 | 1,488 | $976K | 3.2% |
| 12 | $655.85 | 1,488 | $976K | 3.2% |
| 13 | $656.85 | 1,343 | $882K | 2.9% |
| 14 | $656.85 | 1,343 | $882K | 2.9% |
| 15 | $657.84 | 2,860 | $1.9M | 6.1% |
| 16 | $657.84 | 2,860 | $1.9M | 6.1% |
| 17 | $658.92 | 3,660 | $2.4M | 7.9% |
| 18 | $658.92 | 3,660 | $2.4M | 7.9% |
| 19 | $659.75 | 2,859 | $1.9M | 6.1% |
| 20 | $659.75 | 2,859 | $1.9M | 6.1% |
| 21 | $661.10 | 1,200 | $793K | 2.6% |
| 22 | $661.10 | 1,200 | $793K | 2.6% |
| 23 | $662.16 | 1,000 | $662K | 2.2% |
| 24 | $662.16 | 1,000 | $662K | 2.2% |
| 25 | $663.04 | 2,589 | $1.7M | 5.6% |
| 26 | $663.04 | 2,589 | $1.7M | 5.6% |
| Total | $657.55 avg | 46,652 | $30.7M | 100% |
| Filing → |
| IDXX | SELL | 2023-12-06 | $7.3M | — | Filing → |
| IDXX | SELL | 2023-09-05 | $13.7M | — | Filing → |
| IDXX | SELL | 2022-11-16 | $8.9M | — | Filing → |